| All Patients1 (n = 96) | MTB (n = 65) | NTM (n = 31) | P |
---|---|---|---|---|
Age | 32.0 | 32.0 | 34.0 | .43 |
Men | 71 (74.0) | 49 (75.4) | 22 (71.0) | .83 |
Race2 | Â | Â | Â | .05 |
   White | 63 (66.3) | 39 (60.9) | 24 (77.4) |  |
   Black | 23 (24.2) | 20 (31.3) | 3 (9.7) |  |
   Other | 9 (9.5) | 5 (7.8) | 4 (12.9) |  |
HIV exposure | Â | Â | Â | .34 |
   Sexual | 46 (57.5) | 28 (52.8) | 18 (56.7) |  |
   IV drug use | 34 (42.5) | 25 (47.2) | 9 (33.3) |  |
Previous ART | 35 (36.4) | 17 (25.8) | 18 (57.6) | .004 |
Median CD4 (cels/mm3) (No. of patients) | (53) | 42.0 (34) | 13.0 (19) | .002 |
Median viral load (log/mL) (No. of patients) | 5.2 (11) | 4.7 (5) | 5.4 (6) | .83 |
Anti-HCV positive | 26 (35.6) | 18 (37.5) | 8 (32.0) | .83 |
HBsAg positive | 6 (8.8) | 4 (8.5) | 2 (9.5) | .74 |